KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $48,000 | -43.5% | 14,090 | -37.5% | 0.00% | – |
Q2 2018 | $85,000 | -15.8% | 22,546 | -8.3% | 0.00% | – |
Q1 2018 | $101,000 | -30.8% | 24,580 | -21.2% | 0.00% | – |
Q4 2017 | $146,000 | -33.9% | 31,209 | 0.0% | 0.00% | – |
Q3 2017 | $221,000 | +8.9% | 31,209 | +10.7% | 0.00% | – |
Q2 2017 | $203,000 | +26.1% | 28,205 | +8.5% | 0.00% | – |
Q1 2017 | $161,000 | +6.6% | 25,985 | +1.2% | 0.00% | – |
Q4 2016 | $151,000 | +24.8% | 25,685 | +11.4% | 0.00% | – |
Q3 2016 | $121,000 | -24.4% | 23,053 | -4.6% | 0.00% | – |
Q2 2016 | $160,000 | +41.6% | 24,175 | 0.0% | 0.00% | – |
Q1 2016 | $113,000 | -5.0% | 24,175 | -0.0% | 0.00% | – |
Q4 2015 | $119,000 | +38.4% | 24,181 | 0.0% | 0.00% | – |
Q3 2015 | $86,000 | -56.8% | 24,181 | +18.9% | 0.00% | – |
Q2 2015 | $199,000 | -3.9% | 20,344 | +25.5% | 0.00% | – |
Q1 2015 | $207,000 | +5.1% | 16,209 | +17.9% | 0.00% | – |
Q4 2014 | $197,000 | +5.3% | 13,748 | 0.0% | 0.00% | – |
Q3 2014 | $187,000 | – | 13,748 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |